IPCA Laboratories Limited (IPCALAB) Share Analysis
NSE · Healthcare · Pharmaceuticals
IPCA Laboratories Limited (NSE: IPCALAB) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 150. As of 21 Sep 2026, the share price was ₹2,010.00, market capitalisation ₹50,984 Cr, P/E 37.1, ROE 15.7%.
Get the AI verdict on IPCALAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
IPCALAB price and valuation
- Share price
- ₹2,010.00
- Market cap
- ₹50,984 Cr
- P/E ratio
- 37.1
- P/B ratio
- 6.32
- EPS
- ₹51.63
- Book value per share
- ₹318.00
- Dividend yield
- 0.3%
IPCALAB profitability and growth
- ROE
- 15.7%
- ROCE
- 17%
- Debt to equity
- 0.08
- Revenue growth (3 yr)
- 16%
- Revenue growth (5 yr)
- 12%
- Profit growth (3 yr)
- 37%
- Profit growth (5 yr)
- 1%
IPCALAB 52-week range
- 52-week high
- ₹2,038.00
- 52-week low
- ₹1,251.60
- Face value
- ₹1.00
IPCALAB shareholding pattern
- Promoters
- 44.72%
- FIIs
- 10.72%
- DIIs
- 37.04%
- Public
- 7.19%
Index membership: NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.